Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,150.00p
   
  • Change Today:
    -16.50p
  • 52 Week High: 1,208.50
  • 52 Week Low: 896.20
  • Currency: UK Pounds
  • Shares Issued: 874.37m
  • Volume: 2,974,219
  • Market Cap: £10,055m
  • RiskGrade: 173

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart (20-09-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Smith and Nephew Financials

Latest F'cast
Div Yield 2.4% 0.0%
Div Cover 2.2 2.5
Op Mrgn 7.7% 15.9%
ROCE 9.1%  
Latest F'cast
P/E 18.5 16.4
PEG 15.1 n/a
Pr/Revenue 2.4 1.7
Pr/Book 2.6  
Latest F'cast
Revenue 6.4% -21.3%
PBT 23.4% 139.8%
EPS 1.2% -15.4%
DPS n/a -43.1%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 5,138.00 743.00 102.20¢ 23.9 23.9 +1% 37.50¢ 1.5%
31-Dec-20 4,560.00 246.00 64.60¢ 31.1 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 21.3 0.9 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 18.1 18.1 +1% 37.50¢ 2.5%
31-Dec-23 5,549.00 290.00 82.80¢ 17.4 17.4 +1% 37.50¢ 2.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 5,816.36 926.51 70.07p 16.4 n/a -15% 28.45p 0.0%
31-Dec-25 6,129.78 1,093.53 83.68p 13.7 0.7 +19% 32.25p 0.0%
31-Dec-26 6,442.47 1,198.18 93.59p 12.3 1.0 +12% 35.65p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Director/PDMR Shareholding 19-Sep-2024 15:50 RNS
Director/PDMR Shareholding 17-Sep-2024 14:27 RNS
Director/PDMR Shareholding 13-Sep-2024 15:16 RNS

Latest Smith and Nephew Director Deals

Traded Action Notifier PriceAmountValue
16-Sep-24 Buy Simon Lowth 1,189.93p 300 £3,569.78
16-Sep-24 Buy Angie Risley 1,189.93p 312 £3,712.57
05-Aug-24 Buy Rupert Soames 1,166.02p 5,370 £62,615.11

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,150.00p
Change Today -16.50p
% Change -1.41 %
52 Week High 1,208.50
52 Week Low 896.20
Volume 2,974,219
Shares Issued 874.37m
Market Cap £10,055m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.74% below the market average89.74% below the market average89.74% below the market average89.74% below the market average89.74% below the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average
Price Trend
47.64% above the market average47.64% above the market average47.64% above the market average47.64% above the market average47.64% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average
Income
40.26% below the market average40.26% below the market average40.26% below the market average40.26% below the market average40.26% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.13% below the market average36.13% below the market average36.13% below the market average36.13% below the market average36.13% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 6
Sell 0
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-24 28-Mar-24
Paid 08-Nov-24 22-May-24
Amount 14.40¢ 23.10¢

Trades for 20-Sep-2024

Time Volume / Share Price
16:47 10,089 @ 1,150.00p
16:42 3,616 @ 1,150.00p
16:42 7,850 @ 1,150.00p
16:42 4,806 @ 1,150.00p
16:36 55,129 @ 1,150.00p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page